Works matching IS 02780232 AND DT 2023 AND VI 41 AND IP 3

Results: 39

Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 407, doi. 10.1002/hon.3131
By:
- Núñez‐García, Beatriz;
- Clemente, Mariola Blanco;
- Sánchez, Juan Cristóbal;
- Royuela, Ana;
- Ibargüen, Blanca Cantos Sánchez de;
- Méndez, Miriam;
- López‐Ibor, Jorge V.;
- Martínez, Marta;
- Traseira, Cristina;
- Garitaonaindia, Yago;
- Aguado, Ramón;
- Calvo, Virginia;
- Torrente, María;
- Parejo, Consuelo;
- Provencio, Zaida;
- Provencio, Mariano
Publication type:
Article
Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 499, doi. 10.1002/hon.3129
By:
- Cheng, Po‐Liang;
- Hsiao, Tzu‐Hung;
- Chen, Chung‐Hsing;
- Hung, Miao‐Neng;
- Jhan, Pei‐Pei;
- Lee, Li‐Wen;
- Wu, Ting‐Shuan;
- Tsai, Jia‐Rung;
- Teng, Chieh‐Lin Jerry
Publication type:
Article
Risk of a second cancer and infection in patients with indolent B‐cell lymphoma exposed to first‐line bendamustine plus rituximab: A retrospective analysis of an administrative claims database.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 354, doi. 10.1002/hon.3128
By:
- Dote, Satoshi;
- Inose, Ryo;
- Goto, Ryota;
- Kobayashi, Yuka;
- Muraki, Yuichi
Publication type:
Article
COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 555, doi. 10.1002/hon.3127
By:
- Masina, Lorenzo;
- Bianchetti, Nicola;
- Passi, Angela;
- Bottelli, Chiara;
- Bagnasco, Samuele;
- Spolzino, Angelica;
- Oberti, Margherita;
- Chiarini, Marco;
- Belotti, Angelo;
- Voltolini, Simone;
- Faglioni, Laura;
- Rossi, Giuseppe;
- Tucci, Alessandra;
- Cattaneo, Chiara
Publication type:
Article
Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 363, doi. 10.1002/hon.3126
By:
- Mattiello, Veronica;
- Barone, Angelica;
- Giannarelli, Diana;
- Noto, Alessandro;
- Cecchi, Nicola;
- Rampi, Nicolò;
- Cassin, Ramona;
- Reda, Gianluigi
Publication type:
Article
Prognostic value of prognostic nutritional index on extranodal natural killer/T‐cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 380, doi. 10.1002/hon.3124
By:
- Shen, Ziyuan;
- Zhang, Shuo;
- Chen, Xicheng;
- Zhang, Qing;
- Jiao, Yaxue;
- Shi, Yuye;
- Zhang, Hao;
- Ye, Jingjing;
- Wang, Ling;
- Zhu, Taigang;
- Miao, Yuqing;
- Wang, Liang;
- Cai, Guoqi;
- Sang, Wei
Publication type:
Article
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 453, doi. 10.1002/hon.3123
By:
- Kauer, Joseph;
- Sester, Lilli Sophie;
- Kriegsmann, Katharina;
- Weinhold, Niels;
- Ober, Michael;
- Müller‐Tidow, Carsten;
- Goldschmidt, Hartmut;
- Raab, Marc‐Steffen;
- Sauer, Sandra
Publication type:
Article
COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 559, doi. 10.1002/hon.3121
By:
- Del Poeta, Giovanni;
- Laureana, Roberta;
- Bomben, Riccardo;
- Rossi, Francesca Maria;
- Pozzo, Federico;
- Zaina, Eva;
- Cattarossi, Ilaria;
- Varaschin, Paola;
- Nanni, Paola;
- Boschian Boschin, Romina;
- Nunzi, Andrea;
- Postorino, Massimiliano;
- Pasqualone, Gianmario;
- Brisotto, Giulia;
- Steffan, Agostino;
- Muraro, Elena;
- Zucchetto, Antonella;
- Del Principe, Maria Ilaria;
- Gattei, Valter
Publication type:
Article
Knockdown of let‐7b in leukemia associated macrophages inhibit acute myeloid leukemia progression.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 510, doi. 10.1002/hon.3120
By:
- Tian, Chen;
- Li, Yueyang;
- Si, Junqi;
- Kang, Junnan;
- Chen, Zehui;
- Nuermaimaiti, Rexidan;
- Wang, Yafei;
- Yu, Yong;
- Zhao, Zhigang;
- Wang, Xiaofang;
- Zhang, Yizhuo;
- Zhao, Haifeng;
- Yang, Hongliang;
- You, Mingjian James;
- Zheng, Guoguang;
- Wang, Lina
Publication type:
Article
Safety and efficacy of SARS‐Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR‐T cell infusion.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 563, doi. 10.1002/hon.3119
By:
- Metafuni, Elisabetta;
- Cingolani, Antonella;
- Fantoni, Massimo;
- Chiusolo, Patrizia;
- Giammarco, Sabrina;
- Sorà, Federica;
- Galli, Eugenio;
- Hohaus, Stefan;
- D'Alò, Francesco;
- Bellesi, Silvia;
- Maiolo, Elena;
- Alma, Eleonora;
- Laurenti, Luca;
- Innocenti, Idanna;
- Autore, Francesco;
- Limongiello, Maria Assunta;
- Santangelo, Rosaria;
- Marchetti, Simona;
- Ricci, Rosalba;
- Sica, Simona
Publication type:
Article
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 335, doi. 10.1002/hon.3118
By:
- Derenzini, Enrico;
- Gueli, Angela;
- Risso, Alessandra;
- Bruna, Riccardo;
- Gottardi, Daniela;
- Cignetti, Alessandro;
- Pileri, Stefano;
- Avvedimento, Enrico V.;
- Tarella, Corrado
Publication type:
Article
Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 415, doi. 10.1002/hon.3117
By:
- Biggi, Alberto;
- Chauvie, Stephane;
- Fallanca, Federico;
- Guerra, Luca;
- Bergesio, Fabrizio;
- Menga, Massimo;
- Bianchi, Andrea;
- Gregianin, Michele;
- Chiaravalloti, Agostino;
- Schillaci, Orazio;
- Pavoni, Chiara;
- Patti, Caterina;
- Picardi, Marco;
- Romano, Alessandra;
- Schiavotto, Corrado;
- Sorasio, Roberto;
- Viviani, Simonetta;
- La Nasa, Giorgio;
- Trentin, Livio;
- Rambaldi, Alessandro
Publication type:
Article
15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 546, doi. 10.1002/hon.3112
By:
- Mei, Chen;
- Ye, Li;
- Ren, Yanling;
- Zhou, Xinping;
- Ma, Liya;
- Xu, Gaixiang;
- Xu, Weilai;
- Lu, Chenxi;
- Yang, Haiyang;
- Luo, Yingwan;
- Jiang, Lingxu;
- Lang, Wei;
- Zhu, HongHu;
- Jin, Jie;
- Tong, Hongyan
Publication type:
Article
Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin‐dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosis.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 474, doi. 10.1002/hon.3110
By:
- Wang, Fuping;
- Zhang, Haotian;
- He, Binghong;
- Liu, Zihan;
- Wu, Xinxin;
- Liu, Yuankai;
- Xu, Xin;
- Gou, Xiaoxue;
- Wang, Haitao;
- Yang, Qiong
Publication type:
Article
Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 594, doi. 10.1002/hon.3114
By:
- Sun, Kai;
- Chen, Wen‐Min;
- Wang, Xu;
- Zhao, Xiao‐Su;
- Li, Ling‐Di;
- Hao, Yue;
- Wang, Jun;
- Xu, Nan;
- Jiang, Qian;
- Jiang, Hao;
- Xu, Lan‐Ping;
- Wang, Yu;
- Zhang, Xiao‐Hui;
- Huang, Xiao‐Jun;
- Qin, Ya‐Zhen
Publication type:
Article
Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 343, doi. 10.1002/hon.3113
By:
- Assanto, Giovanni Manfredi;
- Di Rocco, Alice;
- Malfona, Francesco;
- Capriata, Marcello;
- Del Giudice, Ilaria;
- Petrucci, Luigi;
- Girardi, Paola;
- D'Elia, Gianna Maria;
- Martelli, Maurizio;
- Gentile, Giuseppe;
- Micozzi, Alessandra;
- Pulsoni, Alessandro
Publication type:
Article
Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 487, doi. 10.1002/hon.3111
By:
- Samara, Aladin;
- Anbar, Michael;
- Shapira, Saar;
- Zemlyansky, Anna;
- Zozovsky, Alla;
- Raanani, Pia;
- Granot, Galit;
- Rozovski, Uri
Publication type:
Article
Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 396, doi. 10.1002/hon.3116
By:
- Tian, Jing;
- Hao, Miaowang;
- Liu, Qiang;
- Xiao, Fang;
- Li, Yuanchun;
- Qi, Meiying;
- Gao, Jing;
- Liu, Li;
- Yin, Dandan
Publication type:
Article
Lenalidomide treatment for recurrent adult T‐cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 389, doi. 10.1002/hon.3115
By:
- Tanaka, Takashi;
- Inamoto, Yoshihiro;
- Ito, Ayumu;
- Watanabe, Mizuki;
- Takeda, Wataru;
- Aoki, Jun;
- Kim, Sung‐Won;
- Fukuda, Takahiro
Publication type:
Article
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 463, doi. 10.1002/hon.3109
By:
- Lee, Wan‐Hsuan;
- Lin, Chien‐Chin;
- Wang, Yu‐Hung;
- Yao, Chi‐Yuan;
- Kuo, Yuan‐Yeh;
- Tseng, Mei‐Hsuan;
- Peng, Yen‐Ling;
- Hsu, Cheng‐An;
- Sun, Hsun‐I;
- Chuang, Yi‐Kuang;
- Hsu, Chia‐Lang;
- Tien, Feng‐Ming;
- Tsai, Cheng‐Hong;
- Chou, Wen‐Chien;
- Hou, Hsin‐An;
- Tien, Hwei‐Fang
Publication type:
Article
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 424, doi. 10.1002/hon.3108
By:
- Asano, Arisa;
- Ri, Masaki;
- Masaki, Ayako;
- Maeda, Yasuhiro;
- Tachita, Takuto;
- Hirade, Kentaro;
- Marumo, Yoshiaki;
- Nakashima, Takahiro;
- Hagiwara, Shinya;
- Kinoshita, Shiori;
- Suzuki, Tomotaka;
- Narita, Tomoko;
- Kusumoto, Shigeru;
- Komatsu, Hirokazu;
- Inagaki, Hiroshi;
- Iida, Shinsuke
Publication type:
Article
Malnutrition diagnosed by GLIM criteria better predicts long‐term outcomes for patients with non‐Hodgkin's lymphoma: A prospective multicenter cohort study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 371, doi. 10.1002/hon.3107
By:
- Zou, Yuanlin;
- Xu, Hongxia;
- Lyu, Quanjun;
- Weng, Min;
- Cui, Jiuwei;
- Shi, Hanping;
- Song, Chunhua
Publication type:
Article
Richter transformation in Chronic Lymphocytic Leukemia.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 293, doi. 10.1002/hon.3106
By:
- Innocenti, Idanna;
- Benintende, Giulia;
- Tomasso, Annamaria;
- Fresa, Alberto;
- Autore, Francesco;
- Larocca, Luigi Maria;
- Laurenti, Luca
Publication type:
Article
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 442, doi. 10.1002/hon.3105
By:
- Sunami, Kazutaka;
- Fuchida, Shin‐ichi;
- Suzuki, Kenshi;
- Ri, Masaki;
- Matsumoto, Morio;
- Shimazaki, Chihiro;
- Asaoku, Hideki;
- Shibayama, Hirohiko;
- Ishizawa, Kenichi;
- Takamatsu, Hiroyuki;
- Ikeda, Takashi;
- Maruyama, Dai;
- Imada, Kazunori;
- Uchiyama, Michihiro;
- Kiguchi, Toru;
- Iyama, Satoshi;
- Murakami, Hirokazu;
- Onishi, Reiko;
- Tada, Keisuke;
- Iida, Shinsuke
Publication type:
Article
The impact of CD56 expression in smoldering myeloma patients on early progression.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 587, doi. 10.1002/hon.3104
By:
- Notarfranchi, Laura;
- Segreto, Roberta;
- Vescovini, Rosanna;
- Dalla Palma, Anna Benedetta;
- Marchica, Valentina;
- Burroughs‐Garcia, Jessica;
- Toscani, Denise;
- Todaro, Giannalisa;
- Raimondi, Vincenzo;
- Iannozzi, Nicolas Thomas;
- Bonomini, Sabrina;
- Sammarelli, Gabriella;
- Craviotto, Luisa;
- Pedrazzoni, Mario;
- Storti, Paola;
- Giuliani, Nicola
Publication type:
Article
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 590, doi. 10.1002/hon.3103
By:
- Suzuki, Tomotaka;
- Maruyama, Dai;
- Machida, Ryunosuke;
- Kataoka, Tomoko;
- Fukushima, Noriyasu;
- Takayama, Nobuyuki;
- Ohba, Rie;
- Omachi, Ken;
- Imaizumi, Yoshitaka;
- Tokunaga, Masahito;
- Katsuya, Hiroo;
- Yoshida, Isao;
- Sunami, Kazutaka;
- Kurosawa, Mitsutoshi;
- Kubota, Nobuko;
- Morimoto, Hiroaki;
- Kobayashi, Miki;
- Yamamoto, Kazuhito;
- Kameoka, Yoshihiro;
- Kagami, Yoshitoyo
Publication type:
Article
The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 323, doi. 10.1002/hon.3102
By:
- Eseonu, Kelechi C.;
- Panchmatia, Jaykar R.;
- Streetly, Matthew J.;
- Grauer, Jonathan N.;
- Fakouri, Bahram
Publication type:
Article
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 535, doi. 10.1002/hon.3101
By:
- Yanagisawa, Ryu;
- Tamaki, Masaharu;
- Tanoshima, Reo;
- Misaki, Yukiko;
- Uchida, Naoyuki;
- Koi, Satoshi;
- Tanaka, Takashi;
- Ozawa, Yukiyasu;
- Matsuo, Yayoi;
- Tanaka, Masatsugu;
- Ikegame, Kazuhiro;
- Katayama, Yuta;
- Matsuoka, Ken‐ichi;
- Ara, Takahide;
- Kanda, Yoshinobu;
- Matsumoto, Kimikazu;
- Fukuda, Takahiro;
- Atsuta, Yoshiko;
- Kato, Motohiro;
- Nakasone, Hideki
Publication type:
Article
Capitalizing on paradoxical activation of the mitogen‐activated protein kinase pathway for treatment of Imatinib‐resistant mast cell leukemia.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 520, doi. 10.1002/hon.3100
By:
- Wilhelm, Thomas;
- Toledo, Marcelo A. S.;
- Simons, Ilka;
- Stuth, Christian;
- Mohta, Vrinda;
- Mülfarth, Ronja;
- Nitsche, Marcus;
- Maschke‐Neuß, Karin;
- Schmitz, Susanne;
- Kaiser, Anne;
- Panse, Jens;
- Christen, Deborah;
- Arock, Michel;
- Zenke, Martin;
- Huber, Michael
Publication type:
Article
Distinguishing myelodysplastic syndromes with moderate‐to‐severe bone marrow fibrosis from triple‐negative primary myelofibrosis based on clinical and genetic covariates.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 598, doi. 10.1002/hon.3091
By:
- Wu, Junying;
- Zhang, Wenjun;
- Zhang, Peihong;
- Qin, Tiejun;
- Xu, Zefeng;
- Sun, Qi;
- Jia, Yujiao;
- Qu, Shiqiang;
- Li, Bing;
- Wang, Huijun;
- Pan, Lijuan;
- Liu, Jinqin;
- Zhang, Yudi;
- Yan, Xin;
- Gale, Robert Peter;
- Xiao, Zhijian
Publication type:
Article
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 301, doi. 10.1002/hon.3088
By:
- Cao, Han‐Yu;
- Li, Ling;
- Xue, Sheng‐Li;
- Dai, Hai‐Ping
Publication type:
Article
Diagnostic relevance of 2‐[<sup>18</sup>F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 434, doi. 10.1002/hon.3085
By:
- Rudolphi‐Solero, Teodoro;
- Triviño‐Ibáñez, Eva María;
- González‐Jiménez, Antonio Daniel;
- Ramos‐Font, Carlos;
- Ríos‐Tamayo, Rafael;
- Rebollo‐Aguirre, Angel Custodio;
- Sánchez‐Sánchez, Rocío
Publication type:
Article
Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 574, doi. 10.1002/hon.3082
By:
- Varettoni, Marzia;
- Zibellini, Silvia;
- Merli, Michele;
- Drandi, Daniela;
- Jiménez, Cristina;
- Furlan, Daniela;
- Ferretti, Virginia Valeria;
- Fabbri, Nicole;
- Dogliotti, Irene;
- Varraso, Chiara;
- Ferrante, Martina;
- Cappello, Emilia;
- Peri, Veronica;
- Cavalloni, Chiara;
- Borriero, Michela;
- Facchetti, Giulia Vittoria;
- Ferrero, Simone;
- Arcaini, Luca;
- Garcia‐Sanz, Ramon
Publication type:
Article
TAFRO syndrome: A disease that known is half cured.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 310, doi. 10.1002/hon.3075
By:
- Chen, Tingting;
- Feng, Chun;
- Zhang, Xinyou;
- Zhou, Jihao
Publication type:
Article
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 578, doi. 10.1002/hon.3071
By:
- Xu, Ning;
- Yu, Erin;
- Ng, Nicole;
- Li, Mingjie;
- Bujarski, Sean;
- Hekmati, Ava;
- Nassir, Isabella;
- Hekmati, Tara;
- Yu, Janna;
- Daniely, David;
- Wang, Cathy S.;
- Kim, Clara;
- Chen, Haiming;
- Berenson, James R.
Publication type:
Article
Long‐term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 583, doi. 10.1002/hon.3055
By:
- Maechler, Melanie;
- Bacher, Ulrike;
- Daskalakis, Michael;
- Nilius, Henning;
- Nagler, Michael;
- Taleghani, Behrouz Mansouri;
- Jeker, Barbara;
- Pabst, Thomas
Publication type:
Article
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 567, doi. 10.1002/hon.3080
By:
- Moia, Riccardo;
- Dondolin, Riccardo;
- De Propris, Maria Stefania;
- Talotta, Donatella;
- Mouhssine, Samir;
- Perutelli, Francesca;
- Reda, Gianluigi;
- Mattiello, Veronica;
- Rigolin, Gian Matteo;
- Motta, Marina;
- Olivieri, Jacopo;
- Fanin, Renato;
- Perbellini, Omar;
- Ferrarini, Isacco;
- Mauro, Francesca Romana;
- Del Giudice, Ilaria;
- Laurenti, Luca;
- Tomasso, Annamaria;
- Gentile, Massimo;
- Frustaci, Anna Maria
Publication type:
Article
Issue Information.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 291, doi. 10.1002/hon.3020
Publication type:
Article
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas.
Published in:
Hematological Oncology, 2023, v. 41, n. 3, p. 571, doi. 10.1002/hon.2989
By:
- Autore, Francesco;
- Fresa, Alberto;
- Innocenti, Idanna;
- Principe, Maria Ilaria Del;
- Maglione, Raffaele;
- Stefanizzi, Caterina;
- Pelliccia, Sabrina;
- Romeo, Azzurra;
- Cimino, Giuseppe;
- Papa, Elena;
- Padua, Laura De;
- Andriani, Alessandro;
- Mengarelli, Andrea;
- Tafuri, Agostino;
- Ditto, Concetta;
- Mauro, Francesca Romana;
- Del Poeta, Giovanni;
- Laurenti, Luca
Publication type:
Article